http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022137045-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f0c665eb6c97ca102d7531ada462b06d |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-102 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70596 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-60 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-564 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-564 |
| filingDate | 2020-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79d621018897e85df9a194d76b09720c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6db87174232a1cf24d44a204c1395b91 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db7761d7dd76534b3a48d56374ba716f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_746f9b70861dfc3a05cef0d7ccd96d39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b35d8350c4bc7b15f97f2ce128a01370 |
| publicationDate | 2022-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2022137045-A1 |
| titleOfInvention | Method for estimating the effectiveness of treatment with an anti-cd20 agent in a patient with rheumatoid arthritis and having had an inadequate response to at least one biotherapy |
| abstract | The present invention relates to a method for estimating the effectiveness of treatment with an anti-CD20 agent in a patient with rheumatoid arthritis and who has had an inadequate response to at least one prior biotherapy, consisting in analysing a biological sample of said patient for the expression of a set of biomarkers, the results of which make it possible to determine whether said agent is a treatment that will engender a beneficial response for said patient. The present invention also relates to a system for estimating the effectiveness of said treatment in said patient comprising means for measuring or receiving data, the expression level of said biomarkers and means for processing these data configured to estimate said effectiveness of said treatment in said patient. |
| priorityDate | 2019-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 269.